Healthcare Market Research Companies in North America play a crucial role in driving innovation, strategy, and informed decision-making across the life sciences and medical device sectors. Behind many of the decisions made by hospitals, medical device companies, and investors are the firms providing the data.
But not all market research firms are created equal.
In this blog, we break down the top 7 healthcare market research companies in North America.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ 1. iData Research: Precision in MedTech Market Intelligence
➜ 2. AlphaSophia: AI-Powered Insights for Pharma Strategists
➜ 3. Clarivate: Deep Research Analytics for Life Sciences
➜ 4. GlobalData: Broad Healthcare Market Coverage
➜ 5. MarketsandMarkets: Fast Forecasts, Wide Focus
➜ 6. Frost & Sullivan: Strategy-Led Market Intelligence
➜ 7. Kalorama Information: Trusted Diagnostics Market Expertise
Key Takeaways
- iData Research leads the MedTech market research space with surgical- and SKU-level precision.
- Clarivate dominates pharma and drug pipeline tracking, offering unmatched R&D insights.
- GlobalData provides a well-rounded, easy-to-navigate healthcare platform for high-level strategic decisions.
- MarketsandMarkets is best for rapid, broad-scope forecasting with decent coverage of thousands of verticals.
- AlphaSophia is emerging fast with AI-driven competitive intelligence for startups and VCs.
- Frost & Sullivan shines in strategic planning and forward-looking innovation.
- Kalorama Information is a trusted name in diagnostics and point-of-care market data.
1. iData Research (Burnaby, Canada – Est. 2005)
iData Research is a MedTech-focused market intelligence firm headquartered in Burnaby, British Columbia. Since 2005, iData has specialized in delivering granular data on medical devices and procedures, covering over 70 countries.
Their flagship offerings include 10-year market forecasts, competitive analysis, procedure volumes, and pricing trends across virtually every medical device category, from orthopedics and dental to cardiovascular and diagnostic imaging.
What sets iData apart is its bottom-up methodology, combining primary interviews with procedure-level analysis to produce highly accurate, clinician-validated forecasts. Its MedSKU and Procedure Tracker platforms offer hospitals, manufacturers, and investors tools to analyze product-level sales and adoption trends in real time.
iData Research Pros:
-
Unmatched depth in MedTech device and procedure data
-
Data available by country, segment, and SKU-level granularity
-
Procedure-based forecasting validated by clinicians
-
Tools like MedSKU and Procedure Tracker for real-time tracking
-
Responsive client service and customization options
iData Research Cons:
-
Limited coverage in pharma/biotech
-
May be too specialized for those seeking broader healthcare insights
Summary:
If you’re in medical technology and need surgical-level data and actionable insights, iData Research is the go-to provider.
📌 Visit iData Research to Learn More:
2. AlphaSophia (Toronto, Canada – Est. 2020)
AlphaSophia is a relatively new player but has carved out a niche with its AI-powered competitive intelligence tools. Headquartered in Toronto, the company aggregates data from clinical trials, patents, publications, and global registries to provide fast insights to life sciences companies. Their platform is particularly popular with venture capitalists and startups looking for quick-read summaries of market trends and unmet needs.
While its datasets aren’t as deep as traditional firms, its strength lies in real-time updates and machine-learning-powered analysis. AlphaSophia is best used for early-phase strategic planning and benchmarking competitors in emerging health sectors.
AlphaSophia Pros:
-
Real-time AI-powered competitive benchmarking
-
Aggregates data from clinical trials, patents, and global databases
-
Especially useful for early-stage planning and VC-backed ventures
-
Clean dashboards with intuitive UX
AlphaSophia Cons:
-
Lacks historical depth compared to legacy firms
-
Minimal procedure-level or MedTech segmentation
-
Limited presence in diagnostics and surgical segments
Summary:
Great for fast, early-phase research or trend-spotting, especially in digital health or emerging tech.
3. Clarivate (Philadelphia, USA – Est. 2016 via Merger)
Clarivate is a global analytics firm formed from the merger of Thomson Reuters’ Intellectual Property & Science business and other data providers. In healthcare, its Cortellis platform provides in-depth pharmaceutical, clinical trial, and pipeline data. The company is best known in pharma and biotech circles for R&D tracking, drug development insights, and patent landscapes.
With a strong reputation among large pharmaceutical firms and regulatory bodies, Clarivate’s platform is ideal for drug discovery, competitor monitoring, and market access strategies.
Clarivate Pros:
-
Industry leader in drug pipeline and patent tracking
-
Cortellis platform widely adopted in big pharma
-
Robust regulatory and R&D datasets
-
Trusted source for clinical trial intelligence
Clarivate Cons:
-
Very limited MedTech and device-level focus
-
High subscription cost for small- to mid-sized teams
Summary:
Clarivate is essential for pharma decision-makers who need drug pipeline and IP strategy support.
4. GlobalData (London, UK / New York, USA – Est. 1999)
GlobalData operates as a broad-spectrum research and consulting firm with strong offerings in healthcare, particularly in MedTech and life sciences. Its competitive edge comes from integrating data across markets, companies, and macro trends into one unified platform. In the U.S., its clients span manufacturers, hospitals, investment firms, and government health departments.
The healthcare segment of GlobalData offers device market forecasts, clinical trial analytics, epidemiology data, and company financials. They also have strong analyst commentary and trend reports that offer high-level overviews and insights into emerging technologies.
GlobalData Pros:
-
Wide coverage of healthcare and life sciences verticals
-
Integrates financials, trials, and market data in one platform
-
Strong epidemiology and clinical trial insights
-
Easy-to-use UI for commercial teams
-
Available analyst commentary on emerging trends
GlobalData Cons:
-
Surface-level data in some niche MedTech areas
-
Some reports may lack deep primary validation
-
Report cadence not always aligned with fast-changing markets
Summary:
A solid choice for general market overviews or for healthcare leaders needing both business and clinical intelligence.
5. MarketsandMarkets (Pune, India / Chicago, USA – Est. 2009)
MarketsandMarkets is a high-volume syndicated research provider offering insights across over 30,000 markets, including healthcare, pharmaceuticals, diagnostics, and medical devices. Its strength lies in fast production and massive topic coverage. Many mid-sized companies use MarketsandMarkets to explore adjacent product areas or gain quick forecasts.
While their reports offer solid macro data, they’re often used as starting points for further in-depth research. The firm has a reputation for speed but sometimes lacks the methodological rigor of more niche players.
MarketsandMarkets Pros:
-
Covers over 30,000 niche markets
-
Fast turnaround on report delivery
-
Cost-effective for scoping exercises
-
Good breadth for entry-level research
MarketsandMarkets Cons:
-
Methodologies vary in rigor
-
Limited interview-based or procedure-specific validation
Summary:
MarketsandMarkets is great for directional guidance across broad verticals, especially for quick scoping.
6. Frost & Sullivan (Santa Clara, USA – Est. 1961)
Frost & Sullivan is one of the oldest market research firms with a long legacy in healthcare, industrial automation, and emerging tech. Its healthcare practice covers medical imaging, diagnostics, health IT, and more recently, digital health and AI applications.
Its competitive benchmarking and growth opportunity reports are popular among commercial teams seeking trend insights and customer sentiment. Many clients rely on Frost & Sullivan for its strategic frameworks and “growth opportunity universe” assessments.
Frost & Sullivan Pros:
-
Strong heritage in healthcare strategy and innovation
-
Thought leadership on digital health, AI, and diagnostics
-
Useful for market entry and strategic planning
-
Frameworks like the Growth Opportunity Universe are well-received
Frost & Sullivan Cons:
-
Reports can be more strategic than tactical
-
Segment depth may vary
-
Less transparent sourcing in some newer areas
Summary:
Ideal for strategic planning and understanding macro-level opportunities, especially in emerging technologies.
7. Kalorama Information (Rockville, USA – Est. 1982)
A division of MarketResearch.com, Kalorama focuses on diagnostics, biotechnology, and point-of-care markets. Their reports are detailed and well-researched, especially in niche medical testing markets. If your business is in lab equipment, genetic testing, or infectious disease diagnostics, Kalorama is a valuable source.
Its emphasis on U.S. and global diagnostics markets makes it a go-to for companies looking to launch or evaluate new IVD products.
Kalorama Pros:
-
Deep specialization in diagnostics, lab testing, and IVD
-
Frequently cited in media and scientific journals
-
Strong methodologies and sourcing
-
Ideal for niche diagnostics and point-of-care analysis
Kalorama Cons:
-
-
Very limited coverage of devices, robotics, or surgical systems
-
Fewer interactive tools or platform offerings compared to competitors
-
Summary:
Best used for diagnostic and clinical lab market intelligence, especially for niche and emerging test segments.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
